Prism Med Ltd (PSDLF) 7.2934 $PSDLF
Prism Medical Ltd. Declares Dividend
Marketwire - Wed Apr 23, 4:26PM CDT
Prism Medical Ltd. ("Prism Medical" or the "Company"

(TSX VENTURE: PM), a leading provider of durable medical equipment and related services to the mobility challenged announced today that its Board of Directors has approved a dividend of $0.08 per common share payable on May 22, 2014 to the shareholders of record on May 14, 2014.
Prism Medical Reports First Quarter Results
Marketwire - Tue Apr 22, 3:42PM CDT
Prism Medical Ltd., ("Prism Medical" or "the Company"

(TSX VENTURE: PM), a leading provider of durable medical equipment and related services to the mobility challenged, today reported financial results for the first quarter (Q1) ended February 28, 2014.
Prism Medical Announces Sale of UK Operations
Marketwire - Fri Apr 11, 11:25AM CDT
Prism Medical Ltd. ("Prism Medical" or the "Company"

(TSX VENTURE: PM), a leading provider of durable medical equipment and related services to the mobility challenged, today announced that it has completed the sale of its UK operations for cash consideration of GBP 30.0 million, or C$54.9 million at current exchange rates. The sale occurred pursuant to a Sale and Purchase Agreement (the "Purchase Agreement"

entered into and completed today with a new company (the "Purchaser"

backed by LDC (Managers) Limited, a UK mid-market private equity firm that is a subsidiary of Lloyds Banking Group. Pursuant to the Purchase Agreement, the Purchaser acquired all of the shares of the Company's UK holding company, Prism UK Medical Limited. Local management of Prism UK Medical Limited, led by Stuart Meldrum, will continue to run the UK operations. The UK operations manufacture and supply safe patient handling products and related services directly to the UK healthcare market as well as to dealers throughout Europe and the Middle East.
Prism Medical Reports Fourth Quarter and Fiscal 2013 Results
Marketwire - Tue Mar 25, 4:52PM CDT
Prism Medical Ltd. ("Prism Medical" or "the Company"

(TSX VENTURE: PM), a leading provider of durable medical equipment and related services to the mobility challenged, today reported financial results for the fourth quarter (Q4) and fiscal year ended November 30, 2013.
Prism Medical Acquires 100% of MedCare Products Inc.
Marketwire - Mon Feb 10, 8:04AM CST
Prism Medical Ltd., ("Prism Medical" or "the Company"

(TSX VENTURE: PM), a leading provider of durable medical equipment and related services to the mobility challenged, today announced that it has acquired an additional 51% ownership interest in MedCare Products Inc. (MedCare), resulting in MedCare becoming a 100% owned subsidiary.
Prism Medical Announces Change in Senior Management Roles
Marketwire - Thu Jan 23, 3:02PM CST
Prism Medical Ltd., ("Prism Medical" or "the Company"

(TSX VENTURE: PM), a leading provider of durable medical equipment and related services to the mobility challenged, today announced a change in senior management roles. Prism Medical UK has developed well over the last few years and is now in a position where there are significant opportunities to grow the business and maximize shareholder value. As result Stuart Meldrum has agreed to again lead the UK team as its CEO in an effort to maximize these opportunities. Andy McIntyre will assume the CEO responsibilities in addition to his current responsibilities as Executive Chairman.
Prism Medical Ltd. Stock Option Amendments
Marketwire - Thu Aug 08, 8:01AM CDT
Prism Medical Ltd. ("Prism Medical" or the "Company"

(TSX VENTURE: PM), a leading provider of durable medical equipment and related services to the mobility challenged, announced today that it has been granted conditional approval from the TSX Venture Exchange Inc. to amend certain stock option agreements affecting options to acquire 247,000 common shares at prices ranging from $4.72 to $5.20, by extending the expiry dates to May 31, 2014. The reason for the amendment is that the Company's stock option plan does not allow for automatic extensions of the "expiry date" of options if the expiry date occurs during a "blackout" period pursuant to the Company's securities trading policy. As a result the optionees may not be able to exercise outstanding options. The Company intends to present an amendment to the stock option plan addressing this issue for approval by the shareholders at the next annual meeting to be held prior to the end of May, 2014.
PM, MDW Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Tue Jul 09, 7:22AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Prism Medical Ltd (NYSE

M), Midway Gold Corp (AMEX:MDW) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
PM, MDW, IPCM, PBP Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Jun 07, 6:08AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Prism Medical Ltd (NYSE

M), Midway Gold Corp (AMEX:MDW), IPC The Hospitalist Co Inc (NASDAQ:IPCM), PowerShares S&P 500 BuyWrite Portfolio (NYSE

BP) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: